Background<br />In acquired immunodeficiency syndrome (AIDS) cases, cytopenias of all major blood cell lines were increasingly recognized in patients with HIV infection. Anemia commonly occurs during HIV infection and has been associated with increased progression to AIDS and decreased survival. The aim of this study was to determine the prevalence of anemia and associated risk factors in adults with HIV-AIDS receiving antiretroviral therapy (ART). <br /><br />Methods<br />A cross sectional study was conducted involving 90 adults with HIV-AIDS. Sociodemographic data were collected using a questionnaire. In all patients, CD4+ lymphocyte counts were performed by means of a PIMA analyzer, while hemoglobin was determined using a Sysmex hematology analyzer. The WHO cutoff value of hemoglobin was adjusted to altitude to define anemia. Mild to moderate anemia was defined as hemoglobin 8-13 g/dL for men and 8-12 g/dL for women. Severe anemia was defined as hemoglobin 8 g/dL. Data was analyzed by using logistic regression test.<br /><br />Results<br />There were 90 subjects with HIV-AIDS in this study. Anemia was found in 50 subjects (55.6%), consisting of 12.2% with mild anemia and 43.4% with moderate to severe anemia. Multiple logistic regression showed that an important risk factor for anemia was low body mass index (BMI) between &lt;17-18.5 (OR=4.20; 95% CI=1.23-14.36). However, the CD4 &lt;350 cells/mm3 was not a significant risk factor for anemia (OR=1.03; 95% CI=0.21-5.04).<br /><br />Conclusions<br />Low BMI increases the risk of anemia in subjects with HIV receiving ART. Better screening for anemia and infectious diseases, and modified harm reduction strategy for injection drug users are primary needs in HIV patients.

The HIV epidemic has particular characteristic on each region. The genetic diversity of HIV-1 would affect variability of HIV virus that could potentially most virulent, pathogenic and high transmission rate. Thus it triggers the disease progresivity more rapidly and caused  a new pandemic of HIV infection. The aim of the study is determine the genetic characteristics of HIV-1 on patient with heterosexual transmission based on gene fragment encoding the glycoprotein-41 (gp41) of HIV envelope. Descriptive analytic method and cross sectional design were attended on VCT clinic Mitra Masyarakat Mimika in March-May 2015. Samples of blood plasma from patient with HIV-1 sexual transmission wer amplified using RT-PCR and nested PCR. Genetic characteristics were analyzed with DNA Sequencing using software Bioedit and Mega 5. Identification using sequence analysis  showed two subtypes of HIV patient in Mimika, which were CRF01_AE and B subtypes. There were 40 patients (87%) identified as having genetic characteristics CRF01_AE. Subtypes B was also identified in 6 heterosexual patients. This study suggest that CRF01_AE have heterosexual transmission risk higher than subtype B. Predominance of CRF01_AE contribute to the rapid spread of the HIV epidemic in Mimika